Investigational Site Number :1560005

Shenyang 110022

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Plasma Cell Myeloma

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling